P-glycoprotein expression in de novo acute myeloid leukemia

Leukemia and Lymphoma

Volumn 27, Issue 3-4, 1997, Pages 257-274

  Del Poeta, Giovanni ^a,b   Venditti, Adriano ^a   Aronica, Germano ^a   Stasi, Roberto ^a   Cox, Maria Cristina ^a   Buccisano, Francesco ^a   Bruno, Antonio ^a   Tamburini, Anna ^a   Suppo, Giovanna ^a   Simone, Maria Domenica ^a   Epiceno, Anna Maria ^a   Del Moro, Beatrice ^a   Masi, Mario ^a   Papa, Giuseppe ^a   Amadori, Sergio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

Author keywords

AML; Flow cytometry; P glycoprotein; Prognosis

Indexed keywords

ANTILEUKEMIC AGENT; CD7 ANTIGEN; GLYCOPROTEIN P; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KARYOTYPE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MONOSOMY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

EID: 9844251213     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709059682     Document Type: Article

References (58)

1. Kartner, N., Riodan, J. R. and Ling, V. (1983). Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 222, 1285-1288.
2. Ma, D. D. F., Davey, R. A., Harman, D. H., Ibister, J. P., Scurr, R. D., Mackertich, S. M., Dowden, G. and Bell, D. R. (1987). Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet, 1, 135-137.
3. Holmes, J., Jacobs, A., Carter, G., Janowska-Wieczorek, A. and Padua, R. A. (1989). Multidrug resistance in hemopoietic cell lines, myelodisplastic syndromes and acute myeloblastic leukaemia. Br J Haematol, 72, 40-44.
4. Carulli, G., Petrini, M., Marini, A. and Ambrogi, F. (1988). P-glycoprotein in acute non-lymphoblastic leukemia and in the blastic crisis of myeloid leukemia. N Engl J Med. 319, 797-798.
5. Marie, J. P., Zittoun, R. and Siki, B. (1991). Multidrug resistance (MDR1) gene expression in adult acute leukemia: Correlation with treatment outcome and in vitro drug sensitivity. Blood, 78, 586-592.
6. Muller, M. R., Lennartz, K., Boogen, C., Nowrousian, M. R., Rajewsky, M. F. and Seeber, S. (1992). Cytotoxicity of adriamycin, idarubicin and vincristine in acute myeloid leukaemia: Chemosensitisation by verapamil in relation to P-glycoprotein expression. Ann Hematol, 65, 206-212.
7. Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O. A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., Ludwig, H. and Lechner, K. (1991). MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst, 83, 708-712.
8. Sato, H., Preisler, H., Day, R., Raza, A., Larson, R., Browman, G., Goldberg, J., Vogler, R., Grunwald, H., Gottlieb, A., Bennett, J., Gottesman, M. and Pastan, I. (1990). MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br J Haematol, 73, 340-345.
9. Zhou, D. C., Marie, J. P., Suberville, A. M. and Zittoun, R. (1992). Relevance of mdr1 gene expression in acute myeloid leukaemia and comparison of different diagnostic methods. Leukemia, 6, 879-885.
10. Solary, E., Bida, J. M., Calvo, F., Chauffert, B., Caillot, D., Mugneret, F., Gauville, G., Tsuruo, T., Carli, P. M. and Guy, H. (1991). P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma. Leukemia, 5, 592-597.
11. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D. and Fiere, D. (1992). Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood. 79, 473-476.
12. Arceci, R. J. (1993). Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood, 81, 2215-2222.
13. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I. and Willingham, M. C. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA, 84, 7735-7738.
14. Nooter, K. and Herweijer, H. (1991). Multidrug resistance (mdr) geners in human cancer.Br J Cancer, 63, 663-669.
15. Ito, Y., Tanimoto, M., Kumazawa, T., Okumura, M., Morishima, Y., Ohno, R. and Saito, H. (1989). Increased P-glycoprotein expression and multidrug-resistance gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial diagnosis and relapsed stage. Cancer, 63, 1534-1538.
16. Mizuno, J., Hara, T., Nagata, M., Tawa, A., Tsuruo, T. and Ueda, K. (1991). Detection of multidrug resistance protein, P-glycoprotein in childhood leukaemia and lymphoma. Eur J Pediatr, 150, 416-418.
17. Sugawara, I., Kodo, H., Ohkochi, E., Hamadas, H., Tsuruo, T. and Mon, S. (1989). High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-defined proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas. Br J Cancer, 60, 538-541.
18. Ino, T., Miyazaki, H., Isogai, M., Nomura, T., Tsuzuki, M., Tsuruo, T., Ezaki, K. and Hirano, M. (1994). Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays and correlation with treatment outcome. Leukemia, 8(9), 1492-1497.
19. Michieli, M., Damiani, D., Geromin, A., Michelutti, A., Fanin, R., Raspadori, D., Russo, D., Visani, G., Dinota, A., Pileri, S., Tsuruo, T., Grandi, M., Baccarani, M. and Tura, S. (1992). Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukaemia. Eur J Haematol, 48, 87-92.
20. Venditti, A., Del Poeta, G., Buccisano, F., Tamburini, A., Cox, C., Stasi, R., Bruno, A., Aronica, G., Maffei, L., Suppo, G., Simone, M. D., Forte, L., Cordero, V., Postorino, M., Tufilli, V., Isacchi, G., Masi, M., Papa, G. and Amadori, S. (1997). Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other FAB subtypes. Blood, (in press).
21. Stasi, R., Tribalto, M., Venditti, A., Del Poeta, G., Aronica, G., Zaccari, G., Rossi, V., Maffei, L. and Papa, G. (1992). Simultaneous occurrence of monoclonal gammopathy and acute secondary leukemia with overexpression of P-glycoprotein. Tumori, 78, 403-406.
22. Del Poeta, G., Stasi, R., Venditti, A., Suppo, G., Aronica, G., Bruno, A., Masi, M., Tabilio, A. and Papa, G. (1994). Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia, 8(3), 388-394.
23. Kartner, N., Everden-Poreille, D., Bradley, G. and Ling, V. (1985). Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature, 316, 820-823.
24. Scheper, R. J., Bulte, J. W. M., Brakker, J. G. P., Quack, J. J., Van Der School, E., Balm, A. J. M., Meijer, C. J. L. M., Broxterman, H. J., Kuiper, C. M., Lankelma, J. and Pinedo. H. M. (1988). Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug resistance. Br J Cancer, 42, 389-394.
25. Grandi, M., Geroni, C. and Giuliani, F. C. (1986). Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin. Br J Cancer, 54, 515-518.
26. Dalton, W. S., Grogan, T. M., Rybski, J. A., Scheper, R. J., Richter, L., Kailey, J., Broxterman, H. J., Pinedo, H. M. and Salmon, S. E. (1989). Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug resistant human myeloma cells: Association with level of drug resistance and drug accumulation. Blood, 73, 747-752.
27. Pileri, S. A., Sabbatini, E., Falini, B., Tazzari, P. L., Gherlinzoni, F., Michieli, M. G., Damiani, D., Zucchini, L., Gobbi, M., Tsuruo, T. and Baccarani, M. (1991). Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas. Histopathology, 19, 131-140.
28. Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Gattringer, C., Huber, H. and Hofmann, J. (1992). Detection of activity of P-glycoprotein in human tumor samples using rhodamine 123. Br J Haematol, 82, 161-168.
29. Stasi, R., Del Poeta, G., Masi, M., Tribalto, M., Venditti, A., Papa, G., Nicoletti, B., Vernole, P., Tedeschi, B., Delaroche, I., Mingarelli, R. and Dallapiccola, B. (1993). Incidence of chromosome abnormalities and clinical significance of karyo-type in de novo acute myeloid leukemia. Cancer Genet Cytogenet, 67, 28-34.
30. Resegotti, L. for the GIMEMA Group (1992). Treatment of acute nonlymphoid leukemia (ANLL) in elderly patients. The GIMEMA experience. Leukemia, 6(suppl 2), 72-75.
31. Avvisati, G., Petti, M. C., Spadea, A., Lazzarino, M., Alessandrino, E. P., Liso, V., Specchia, G., Carella, A. M., Falda, M., Fioritoni, G., Ladogana, F. and Mandelli, F. for the cooperative group GIMEMA (1991). Idarubicin (IDA) treatment in acute promyelocytic leukemia (APL): the GIMEMA experience. Haemaiologica, 76(suppl 4), 10.
32. Zittoun, R., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., Leoni, F., Damasio, E., Visani, G., Papa, G., Caronia, F., Hayat, M., Stryckmans, P., Rotoli, B., Leoni, P., Peetermans, M., Dardenne, M., Vegna, M. L., Petti, M. C., Solbu, G. and Suciu, S., for the EORTC and the GIMEMA Leukemia Cooperative Groups (1995). Autologous or allogeneic bone marrow tranplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med. 332, 217-223.
33. Zittoun, R., Liso, V., Mandelli, F., Rotoli, B., de Witte, T., Gattringer, C., Resegotti, L., Caronia, F., Leoni, P., Petti, M. C., Solbu, G., Vegna, M. L. and Suciu, S., for the EORTC Leukemia Cooperative Group and the GIMEMA Group (1992). Intensive consolidation chemotherapy vs. standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC- Gimema phase III trial (AML 8B). Leukemia, 6(suppl 2), 76-77.
34. Heil, G., Hoelzer, D., Sanz, M. A., Lechner, K., Liu Yin, J., Papa, G., Noens, L., Ho, J., O'Brien, C, Matcham, J. and Barge, A. on behalf of the AML study group in Germany. Spain, Austria, United Kingdom, Italy, Belgium, Australia, Sweden and Portugal (1995). Results of a randomised, double blind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukemia. Blood, 86, 1053, (abstr).
35. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1985). Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med, 103, 620-625.
36. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, A. G., Gralnick, H. R. and Sultan, C. (1991). Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-M0). Br J Haematol, 78, 325-329.
37. Muller, M. R., Lennartz, K., Nowrousian, M. R., Dux, R., Tsuruo, T., Rajewsky, M. F. and Seeber, S. (1994). Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis. Cytometiy, 15, 64-72.
38. Hart, S. M., Ganeshaguru, K., Lyttelton, M. P., Prentice, H. G., Hoffbrand, A. V. and Mehta, A. B. (1993). Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.Leuk-Lymphoma, 11, 239-248.
39. + acute myeloblastic/ acute lymphoblastic leukemia. Blood, 82, 3445-3451.
40. Schinkel, A. H., Roelofs, M. E. M. and Borst, P. (1991). Characterization of human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res, 51, 2628-2635.
41. Thiebault, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I. and Willingham, M. C. (1989). Immunocytochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J Histochem Cytochem, 37, 159-164.
42. Cenciarelli, C., Currier, S. J., Willingham, M. C., Thiebaut, F., Germann, U. A., Rutheford, A. V., Gottesman, M. M., Barca, S., Tombesi, M., Morrone, S., Santoni, A., Mariani, M., Ramoni, C., Dupuis, M. L. and Cianfriglia, M. (1991). Characterization by somatic cell genetics of a monoclonal antibody to the MDR1 gene product (P-glycoprotein): determination of P-glycoprotein expression in multi-drug resistant KB and CEM cell variants. Int J Cancer, 47, 533-543.
43. Hamada, H. and Tsuruo, T. (1986). Functional role for the 170-180 kDa glycoprotein in drug resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA, 83, 7785-7789.
44. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I. and Willingham, M. C. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA, 84, 7735-7738.
45. Xie, X.-Y., Robb, D., Chow, S. and Hedley, D. W. (1995). Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia. Leukemia, 9, 1882-1887.
46. Ferrand, V. L., Montero Julian, F. A., Chauvet, M. M., Hirn, M. H. and Bourdeaux, M. J. (1996). Quantitative determination of the MDR-related P-glycoprotein, PgP 170, by a rapid flow cytometric technique. Cytometry, 23, 120-125.
47. Nuessler, V., Pelka-Fleischer, R., Nerl, C., Beckert, B. and Wilmanns, W. (1991). P-glycoprotein expression in patients with acute leukemia, chronic leukemia and myelodysplastic syndromes. J Cancer Res Clin Oncol, 117 (Suppl 3). S114.
48. Sato, H., Gottesman, M. M., Goldstein, L. J., Pastan, I., Block, A. M., Sandberg, A. A. and Preisler, H. D. (1990). Expression of the multidrug resistance gene in myeloid leukemias. Leuk Res, 14, 11-22.
49. Musto, P., Melillo, L., Lombardi, G., Matera, R., Di Giorgio, G. and Carotenuto, M. (1991). High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission. Br J Haematol, 77, 50-53.
50. Paietta, E., Andersen, J., Racevskis, J., Gallagher, R., Bennett, J., Yunis, J., Cassileth, P. and Wiernik, P. H. (1994). Significantly lower P-glycoprotein expression in acute promyelocitic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses. Leukemia, 8(6), 963-973.
51. Fojo, A., Lebo, R., Shimizu, N., Chin, Je, Roninson, I. B., Merlino, G. T., Gottesman, M. M. and Pastan, I. (1986). Localization of multidrug resistance associated DNA sequences to human chromosome 7. Somatic Cell Mol Genet, 12, 415-120.
52. Kuss, B. J., Deeley, R. G., Cole, S. P., Willman, C. L., Kopecky, K. J., Wolman, S. R., Eyre, H. J., Lane, S. A., Nancarrow, J. K. and Whitmore, S. A. (1994). Deletion of gene for multidrug resistance in acute myeloid leukemia with inversion of chromosome 16: prognostic implications. Lancet, 343, 1531-1534.
53. Del Poeta, G., Stasi, R., Aronica, G., Venditti, A., Cox, M. C., Bruno, A., Buccisano, F., Masi, M., Tribalto, M., Amadori, S. and Papa, G. (1996). Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood, 87, 1997-2004.
54. + acute myeloid leukemia cells. Blood, 85, 3157-3162.
55. Leith, P. C., Chen, M. I., Kopecky, K. J., Appelbaum, F. R., Head, D. R., Godwin, J. E., Weick, J. K. and Willman, C. L. (1995). Correlation of multidrug resistance (MDRI) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR+/efflux- cases. Blood, 86, 2329-2342.
56. Kuwazuru, Y., Yoshimura, A., Hanada, S., Utsunomiya, A., Makino, T., Ishibashi, K., Kodama, M., Iwahashi, M., Arima, T. and Akiyama, S. I. (1990). Expression of the multidrug transporter P-glycoprotein in acute leukemia cells and correlation to clinical drug resistance. Cancer, 66, 868-873.
57. Herweijer, H., Sonneveld, P., Baas, F. and Nooter, K. (1990). Expression of MDR1 and MDR3 multidrug resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporin. J Natl Cancer Inst, 82, 1133-1140.
58. Goldstein, L. J., Hanan, G., Fojo, A., Willingham, M., Lai, S. L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M. and Lieber, M. (1989). Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst, 81, 116-124.